2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Abstract Number: 2536

Vagus Nerve Stimulation in Patients with Rheumatoid Arthritis: 24 Month Safety and Efficacy
Abstract Number: 2400

Validating and Developing a Selected Questionnaire to Predict Early Diagnosis of Juvenile Idiopathic Arthritis in German Population
Abstract Number: 1673

Validation and Evaluation of the Spanish Version of the Systemic LUPUS Activity Questionnaire in an Argentine Population
Abstract Number: 647

Validation of a New Electronic Spinal Mobility Index for Patients with Axial Spondyloarthritis Based on Inertial Motion Unit (IMU) Sensors
Abstract Number: 1378

Validation of a Spanish Version of the Functional Index for Hand Osteoarthritis (FIHOA)
Abstract Number: 653

Validation of Assessments in Spondyloarthritis International Society MRI Lesion Definitions in Axial Spondyloarthritis: Data from the Echography in Spondyloarthritis Cohort
Abstract Number: 1540

Validation of Hepatic Fibrosis Markers in People with Rheumatoid Arthritis on Methotrexate
Abstract Number: 2928

Validation of New Systemic Lupus Erythematosus Classification Criteria
Abstract Number: 1712

Validation of Proposed EULAR/Acr SLE Classification Criteria Versus SLICC SLE Classification Criteria
Abstract Number: 2929

Validation of Remission and Lupus Low Disease Activity State As Predictors of Organ Damage in SLE
Abstract Number: 458

Validation of the 2012 Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria Compared to the 1997 Acr Criteria and 2017 Candidate Weighted Criteria for Lupus in Pediatric Patients
Abstract Number: 1338

Validation of the Diagnostic Accuracy of Myositis-Related Antibodies in a Large Patient-Cohort
Abstract Number: 2728

Validation of the Draft Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Indian Patients with ANCA Associated Vasculitis
Abstract Number: 200

Validation of the Ers-RA Risk Score in a Dutch Population
Abstract Number: 2471

Validation of the Functional Index for Hand Osteoarthritis (FIHOA) in Patients with Rheumatoid Arthritis
Abstract Number: 671

Validation of the Rexspa (Reductive X-Ray Score for Psoriatic Arthritis) in an Argentinean Cohort of Patients with Psoriatic Arthritis
Abstract Number: 302

Validity and Responsiveness of Inflammation and Joint Damage Scores Based on the Omeract Rheumatoid Arthritis MRI Scoring System
Abstract Number: 1635

Validity of Patient-Reported Outcomes Measurement Information System Measures in Ankylosing Spondylitis Patients
Abstract Number: 1837

Validity of the Cognitive Index of the Symptom Severity Scale (SSS-Cog) in Assessing Cognitive Impairment in Fibromyalgia Patients
Abstract Number: 1484

Value of Anti-RA33 Isotypes in an European Rheumatoid Arthritis Patient Cohort
Abstract Number: 2736

Value of Histology for Diagnosis and Classification in ANCA Associated Vasculitis
Abstract Number: 2724

Variable Response to Induction Therapy and Significant Burden of Treatment Adverse Events over the First 12 Months in Incident ANCA-Associated Vasculitis (AAV) Patients – a Study of Routine Clinical Practice in the EU
Abstract Number: 1683

Variation in HEp-2 Antinuclear Antibody (ANA) Titer Is Strongly Associated with the ANA Kit Manufacturer
Abstract Number: 2872

Variation in Predictors of Patient and Physician Defined Flares in Rheumatoid Arthritis
Abstract Number: 1060

Variation in the Synovial Fluid Metabolome According to Disease Activity in Rheumatoid Arthritis
Abstract Number: 279

Variations and Disparities in Healthcare Teams Among Individuals with Lupus
Abstract Number: 2008

Vascular Adhesion Protein-1 (VAP-1) As Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis
Abstract Number: 2075

Vascular Endothelial and Inflammatory Differences in Psoriasis and Psoriatic Arthritis Patients
Abstract Number: 2993

Vascular Involvement in Behcet’s Syndrome May be Associated with Subclinical Atherosclerosis
Abstract Number: 2364

Vasculitis Patient Journey: A Scoping Review of Patient Experiences with Vasculitis
Abstract Number: 2721

Venous Thromboembolism in ANCA Associated Vasculitis. a Population-Based Cohort Study from Southern Sweden
Abstract Number: 1794

Venous Vessel Wall Thickness in Lower Extremity Is Increased in Male Behcet’s Disease Patients
Abstract Number: 2337

Vertebral Compression Fractures and Antibodies to Citrullinated Vimentin in Established Rheumatoid Arthritis
Abstract Number: 1731

Vertebral Fracture Prevalence and Measurement of the Scanographic Bone Attenuation Coefficient on CT-Scan in 70 Patients with Systemic Scleroderma
Abstract Number: L07

VIB4920, a Novel, Engineered CD40L Antagonist Decreased Disease Activity and Improved Biomarkers of Immune Activation in Patients with Active Rheumatoid Arthritis in a Phase 1b, Multiple-Ascending Dose Proof-of-Concept Study
Abstract Number: 504

Views of Primary Care Physicians and Rheumatologists Regarding Screening and Management of Hyperlipidemia Among Patients with Rheumatoid Arthritis
Abstract Number: 222

Viral Exposures As a Risk Factor for Rheumatoid Arthritis: Summarizing the Evidence
Abstract Number: 2454

Virus Reactivation Rate in Rheumatoid Arthritis Using Tofacitinib
Abstract Number: 818

Visual Involvement in Giant Cell Arteritis: A Prospective Multi Center Study
Abstract Number: 1557

Visualization of Dorsal Root Ganglionitis with Three-Tesla Magnetic Resonance Neurography in Sensory Ataxic Neuropathy Associated with Sjögren’s Syndrome
Abstract Number: 2330

Vitamin D and Bisphosphonate Therapy in SLE Patients Who Receive Glucocorticoids: Are We Offering the Best Care?

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].